Suppr超能文献

危重症患者使用胶体液或晶体液进行液体复苏:随机试验的系统评价

Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.

作者信息

Schierhout G, Roberts I

机构信息

Department of Epidemiology and Public Health, University College London Medical School.

出版信息

BMJ. 1998 Mar 28;316(7136):961-4. doi: 10.1136/bmj.316.7136.961.

Abstract

OBJECTIVE

To determine the effect on mortality of rescuscitation with colloid solutions compared with resuscitation with crystalloids.

DESIGN

Systematic review of randomised controlled trials of resuscitation with colloids compared with crystalloids for volume replacement of critically ill patients; analysis stratified according to patient type and quality of allocation concealment.

SUBJECTS

37 randomised controlled trials were eligible, of which 26 unconfounded trials compared colloids with crystalloids (n = 1622). (The 10 trials that compared colloid in hypertonic crystalloid with isotonic crystalloid (n = 1422) and one trial that compared colloid in isotonic crystalloid with hypertonic crystalloid (n = 38) are described in the longer version on our website www.bmj.com).

MAIN OUTCOME MEASURES

Mortality from all causes at end of follow up for each trial.

RESULTS

Resuscitation with colloids was associated with an increased absolute risk of mortality of 4% (95% confidence interval 0% to 8%), or four extra deaths for every 100 patients resuscitated. The summary effect measure shifted towards increased mortality with colloids when only trials with adequate concealment of allocation were included. There was no evidence for differences in effect among patients with different types of injury that required fluid resuscitation.

CONCLUSIONS

This systematic review does not support the continued use of colloids for volume replacement in critically ill patients.

摘要

目的

确定与晶体液复苏相比,胶体液复苏对死亡率的影响。

设计

对危重症患者容量替代时胶体液与晶体液复苏的随机对照试验进行系统评价;根据患者类型和分配隐藏质量进行分层分析。

研究对象

37项随机对照试验符合条件,其中26项无混杂因素的试验比较了胶体液与晶体液(n = 1622)。(10项比较高渗晶体液中的胶体液与等渗晶体液的试验(n = 1422)以及1项比较等渗晶体液中的胶体液与高渗晶体液的试验(n = 38)在我们的网站www.bmj.com上的较长版本中有描述)。

主要结局指标

每项试验随访结束时的全因死亡率。

结果

胶体液复苏与死亡率的绝对风险增加4%相关(95%置信区间0%至8%),即每100例接受复苏的患者中有4例额外死亡。当仅纳入分配隐藏充分的试验时,汇总效应量显示胶体液复苏使死亡率增加。对于需要液体复苏的不同类型损伤患者,未发现效应存在差异的证据。

结论

本系统评价不支持继续将胶体液用于危重症患者的容量替代。

相似文献

8
Colloids versus crystalloids for fluid resuscitation in critically ill people.胶体液与晶体液用于危重症患者的液体复苏
Cochrane Database Syst Rev. 2018 Aug 3;8(8):CD000567. doi: 10.1002/14651858.CD000567.pub7.

引用本文的文献

3
Albumin: a comprehensive review and practical guideline for clinical use.白蛋白:临床应用的全面综述与实用指南。
Eur J Clin Pharmacol. 2024 Aug;80(8):1151-1169. doi: 10.1007/s00228-024-03664-y. Epub 2024 Apr 12.

本文引用的文献

5
Regional and institutional variation in burn care.烧伤护理的地区和机构差异。
J Burn Care Rehabil. 1995 Jan-Feb;16(1):86-90; discussion 85. doi: 10.1097/00004630-199501000-00017.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验